BioCentury | Jan 7, 2016
Distillery Therapeutics

Therapeutics: Transforming growth factor β1 (TGFβ1)

...Amgen also has G207 , a modified HSV-1, in Phase I to treat brain cancer. Karcinolys S.A.S....
Items per page:
1 - 1 of 1
BioCentury | Jan 7, 2016
Distillery Therapeutics

Therapeutics: Transforming growth factor β1 (TGFβ1)

...Amgen also has G207 , a modified HSV-1, in Phase I to treat brain cancer. Karcinolys S.A.S....
Items per page:
1 - 1 of 1